{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Lumacaftor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lumacaftor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lumacaftor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "lumacaftor",
    "trial_2_text": "Lumacaftor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Lumacaftor Supplement: 60 participants will take Lumacaftor 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lumacaftor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lumacaftor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "188": 0.3137212097644806,
      "189": 0.3095848262310028,
      "87": 0.2677907347679138,
      "78": 0.2576877176761627,
      "173": 0.24776042997837067,
      "243": 0.2303989976644516,
      "123": 0.21037514507770538,
      "37": 0.2097957879304886,
      "64": 0.20216377079486847,
      "20": 0.1817263960838318,
      "77": 0.17901448905467987,
      "9": 0.17481312155723572,
      "21": 0.17439481616020203,
      "200": 0.17092828452587128,
      "177": 0.1666051596403122,
      "350": 0.15873420238494873,
      "14": 0.15822792053222656,
      "28": 0.15741665661334991,
      "228": 0.1499231606721878,
      "114": 0.1465616077184677,
      "17": 0.1456376016139984,
      "67": 0.14172585308551788,
      "68": 0.14029709994792938,
      "49": 0.13603174686431885,
      "131": 0.1346748173236847,
      "126": 0.13414470851421356,
      "46": 0.130294531583786,
      "85": 0.1294422745704651,
      "2": 0.1269819736480713,
      "193": 0.12562209367752075,
      "204": 0.12483709305524826,
      "139": 0.12123748660087585,
      "97": 0.12058819830417633,
      "132": 0.12057836353778839,
      "30": 0.1193586215376854,
      "116": 0.11932890117168427,
      "261": 0.11820157617330551,
      "5": 0.11748049408197403,
      "79": 0.11455114930868149,
      "508": 0.11310110986232758,
      "36": 0.11094029247760773,
      "101": 0.1103382408618927,
      "86": 0.1088399663567543,
      "454": 0.10817167907953262,
      "747": 0.1072898730635643,
      "441": 0.10662136971950531,
      "69": 0.10635172575712204,
      "138": 0.10425898432731628,
      "29": 0.10378377139568329,
      "147": 0.10250959545373917,
      "341": 0.10230045765638351,
      "179": 0.09993630647659302,
      "92": 0.09955860674381256,
      "194": 0.09909343719482422,
      "186": 0.09658479690551758,
      "104": 0.09506093710660934,
      "239": 0.09496721625328064,
      "18": 0.0941808819770813,
      "151": 0.09384651482105255,
      "102": 0.09372230619192123,
      "76": 0.0936150923371315,
      "61": 0.09356824308633804,
      "99": 0.09194925427436829,
      "35": 0.09135439991950989,
      "82": 0.08883453160524368,
      "363": 0.08643335849046707,
      "38": 0.08489090949296951,
      "297": 0.08444920182228088,
      "356": 0.08422493189573288,
      "166": 0.08390330523252487,
      "136": 0.0836033970117569,
      "72": 0.08349806070327759,
      "456": 0.0822906494140625,
      "118": 0.08220374584197998,
      "191": 0.0821504071354866,
      "396": 0.08178357779979706,
      "211": 0.0810418352484703,
      "105": 0.0788557380437851,
      "286": 0.07611002773046494,
      "84": 0.07533293217420578,
      "122": 0.07392128556966782,
      "339": 0.07257235050201416,
      "535": 0.07219067215919495,
      "466": 0.07215484231710434,
      "276": 0.07133323699235916,
      "382": 0.07113639265298843,
      "269": 0.07065942883491516,
      "11": 0.07028737664222717,
      "195": 0.07014097273349762,
      "342": 0.06900204718112946,
      "422": 0.06801126152276993,
      "130": 0.06721212714910507,
      "33": 0.06695424765348434,
      "522": 0.06549105793237686,
      "345": 0.06511291861534119,
      "4": 0.06383219361305237,
      "94": 0.06372269988059998,
      "27": 0.06277690082788467,
      "371": 0.06229349225759506,
      "98": 0.06089905649423599
    },
    "trial_2_ae": {
      "188": 0.3137212097644806,
      "189": 0.3095848262310028,
      "87": 0.2677907347679138,
      "78": 0.2576877176761627,
      "173": 0.24776042997837067,
      "243": 0.2303989976644516,
      "123": 0.21037514507770538,
      "37": 0.2097957879304886,
      "64": 0.20216377079486847,
      "20": 0.1817263960838318,
      "77": 0.17901448905467987,
      "9": 0.17481312155723572,
      "21": 0.17439481616020203,
      "200": 0.17092828452587128,
      "177": 0.1666051596403122,
      "350": 0.15873420238494873,
      "14": 0.15822792053222656,
      "28": 0.15741665661334991,
      "228": 0.1499231606721878,
      "114": 0.1465616077184677,
      "17": 0.1456376016139984,
      "67": 0.14172585308551788,
      "68": 0.14029709994792938,
      "49": 0.13603174686431885,
      "131": 0.1346748173236847,
      "126": 0.13414470851421356,
      "46": 0.130294531583786,
      "85": 0.1294422745704651,
      "2": 0.1269819736480713,
      "193": 0.12562209367752075,
      "204": 0.12483709305524826,
      "139": 0.12123748660087585,
      "97": 0.12058819830417633,
      "132": 0.12057836353778839,
      "30": 0.1193586215376854,
      "116": 0.11932890117168427,
      "261": 0.11820157617330551,
      "5": 0.11748049408197403,
      "79": 0.11455114930868149,
      "508": 0.11310110986232758,
      "36": 0.11094029247760773,
      "101": 0.1103382408618927,
      "86": 0.1088399663567543,
      "454": 0.10817167907953262,
      "747": 0.1072898730635643,
      "441": 0.10662136971950531,
      "69": 0.10635172575712204,
      "138": 0.10425898432731628,
      "29": 0.10378377139568329,
      "147": 0.10250959545373917,
      "341": 0.10230045765638351,
      "179": 0.09993630647659302,
      "92": 0.09955860674381256,
      "194": 0.09909343719482422,
      "186": 0.09658479690551758,
      "104": 0.09506093710660934,
      "239": 0.09496721625328064,
      "18": 0.0941808819770813,
      "151": 0.09384651482105255,
      "102": 0.09372230619192123,
      "76": 0.0936150923371315,
      "61": 0.09356824308633804,
      "99": 0.09194925427436829,
      "35": 0.09135439991950989,
      "82": 0.08883453160524368,
      "363": 0.08643335849046707,
      "38": 0.08489090949296951,
      "297": 0.08444920182228088,
      "356": 0.08422493189573288,
      "166": 0.08390330523252487,
      "136": 0.0836033970117569,
      "72": 0.08349806070327759,
      "456": 0.0822906494140625,
      "118": 0.08220374584197998,
      "191": 0.0821504071354866,
      "396": 0.08178357779979706,
      "211": 0.0810418352484703,
      "105": 0.0788557380437851,
      "286": 0.07611002773046494,
      "84": 0.07533293217420578,
      "122": 0.07392128556966782,
      "339": 0.07257235050201416,
      "535": 0.07219067215919495,
      "466": 0.07215484231710434,
      "276": 0.07133323699235916,
      "382": 0.07113639265298843,
      "269": 0.07065942883491516,
      "11": 0.07028737664222717,
      "195": 0.07014097273349762,
      "342": 0.06900204718112946,
      "422": 0.06801126152276993,
      "130": 0.06721212714910507,
      "33": 0.06695424765348434,
      "522": 0.06549105793237686,
      "345": 0.06511291861534119,
      "4": 0.06383219361305237,
      "94": 0.06372269988059998,
      "27": 0.06277690082788467,
      "371": 0.06229349225759506,
      "98": 0.06089905649423599
    }
  },
  "safety": {
    "trial_1_safety": 0.265807569026947,
    "trial_2_safety": 0.265807569026947
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47715988755226135
  }
}